Search - tctmd.com

Displaying 81 - 100 of 103

Sort: Relevancy | Date

Presentation

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Presenter: Francis Couturaud

July 10, 2015

News Daily News

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

L.A. McKeown

July 08, 2015

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Industry News

Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C

June 25, 2015

News Industry News

Knowledge Gaps and Misperceptions on Impact of Atrial Fibrillation and Stroke Exist Among Patients, Caregivers and Physicians

May 13, 2015

News Daily News

Silent A-fib After Acute MI Portends Poor Outcome

Yael L. Maxwell

May 01, 2015

News Daily News

La Fibrilación Auricular Post-IAM Acarrea Malos Resultados

Yael L. Maxwell

May 01, 2015

News Daily News

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Todd Neale

January 28, 2015

News Daily News

慢性维生素K拮抗剂使用会增加直接PCI患者的院内出血

Caitlin E. Cox

November 02, 2014

News Daily News

El Uso Crónico de un Antagonista de la Vitamina K Aumenta las Hemorragias Intrahospitalarias en Pacientes sometidos a PCI Primarias

Caitlin E. Cox

November 02, 2014

News Daily News

Chronic Vitamin K Antagonist Use Ups In-Hospital Bleeding Among Primary PCI Patients

Caitlin E. Cox

November 02, 2014

Presentation Cardiovascular Interventions 2014

How to Manage Post PCI Antiplatelet Therapy in the Patient on Oral Anticoagulation

Presenter: David P. Faxon

October 23, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Daily News

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

September 02, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

Presentation TCT 2013

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

Presenter: Harvey White

October 31, 2013

News Daily News

ESC Offers Recommendations on Use of New Oral Anticoagulants

Yael L. Maxwell

May 03, 2013

News Daily News

Danish Registry: Dabigatran Safe, Effective in Real-World Use

Caitlin E. Cox

April 05, 2013

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

Advertisement

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C

Knowledge Gaps and Misperceptions on Impact of Atrial Fibrillation and Stroke Exist Among Patients, Caregivers and Physicians

Silent A-fib After Acute MI Portends Poor Outcome

La Fibrilación Auricular Post-IAM Acarrea Malos Resultados

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

慢性维生素K拮抗剂使用会增加直接PCI患者的院内出血

El Uso Crónico de un Antagonista de la Vitamina K Aumenta las Hemorragias Intrahospitalarias en Pacientes sometidos a PCI Primarias

Chronic Vitamin K Antagonist Use Ups In-Hospital Bleeding Among Primary PCI Patients

How to Manage Post PCI Antiplatelet Therapy in the Patient on Oral Anticoagulation

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

ESC Offers Recommendations on Use of New Oral Anticoagulants

Danish Registry: Dabigatran Safe, Effective in Real-World Use

Evidence Continues to Support Dabigatran Treatment in A-fib

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content